Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fortin

Showing results (31-40 of 329) with videos related to

Pageof 33
Sort By:
The Journal of Rheumatology|April 12, 2001
The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosusC Wang, N E Mayo, P R Fortin
Current Opinion in Rheumatology|May 3, 2011
Infections in the lupus patient: perspectives on preventionClaire Barber, Wayne L Gold, Paul R Fortin
British Journal of Rheumatology|February 11, 1999
A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGES Ligier, P R Fortin, M M Newkirk
Thrombosis and Haemostasis|December 30, 1998
Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombinJ Rauch, M Tannenbaum, C Neville, et al.
Journal of Clinical Epidemiology|May 15, 2002
Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physiciansErika Chang, Michal Abrahamowicz, Diane Ferland, et al.
BMC Genomics|August 23, 2002
Mouse ribonuclease III. cDNA structure, expression analysis, and chromosomal locationKristine R Fortin, Rhonda H Nicholson, Allen W Nicholson
Journal of Leukocyte Biology|April 15, 2026
Neutrophil FcγRI expression as a determinant of oxidative responses in human bloodSandrine Huot, Paul R Fortin, Cynthia Laflamme, et al.
The Journal of Rheumatology|November 5, 2002
Organ manifestations influence differently the responsiveness of 2 lupus disease activity measures, according to patients' or physicians' evaluations of recent lupus activityErika R Chang, Michal Abrahamowicz, Diane Ferland, et al.
The Journal of Rheumatology|March 25, 1999
Systemic lupus erythematosus, a disease associated with low levels of clusterin/apoJ, an antiinflammatory proteinM M Newkirk, P Apostolakos, C Neville, et al.
Science (New York, N.Y.)|March 20, 1970
Intestinal enzymes: indicators of proliferation and differentiation in the jejunumR Fortin-Magana, R Hurwitz, J J Herbst, et al.
Pageof 33

Showing results (31-40 of 329) with videos related to

Sort By:
Pageof 33
The Journal of Rheumatology|April 12, 2001
The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosusC Wang, N E Mayo, P R Fortin
Current Opinion in Rheumatology|May 3, 2011
Infections in the lupus patient: perspectives on preventionClaire Barber, Wayne L Gold, Paul R Fortin
British Journal of Rheumatology|February 11, 1999
A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGES Ligier, P R Fortin, M M Newkirk
Thrombosis and Haemostasis|December 30, 1998
Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombinJ Rauch, M Tannenbaum, C Neville, et al.
Journal of Clinical Epidemiology|May 15, 2002
Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physiciansErika Chang, Michal Abrahamowicz, Diane Ferland, et al.
BMC Genomics|August 23, 2002
Mouse ribonuclease III. cDNA structure, expression analysis, and chromosomal locationKristine R Fortin, Rhonda H Nicholson, Allen W Nicholson
Journal of Leukocyte Biology|April 15, 2026
Neutrophil FcγRI expression as a determinant of oxidative responses in human bloodSandrine Huot, Paul R Fortin, Cynthia Laflamme, et al.
The Journal of Rheumatology|November 5, 2002
Organ manifestations influence differently the responsiveness of 2 lupus disease activity measures, according to patients' or physicians' evaluations of recent lupus activityErika R Chang, Michal Abrahamowicz, Diane Ferland, et al.
The Journal of Rheumatology|March 25, 1999
Systemic lupus erythematosus, a disease associated with low levels of clusterin/apoJ, an antiinflammatory proteinM M Newkirk, P Apostolakos, C Neville, et al.
Science (New York, N.Y.)|March 20, 1970
Intestinal enzymes: indicators of proliferation and differentiation in the jejunumR Fortin-Magana, R Hurwitz, J J Herbst, et al.
Pageof 33